Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial

por Videnovic, Aleksandar, Amara, Amy W., Comella, Cynthia, Schweitzer, Paula K., Emsellem, Helene, Liu, Kris, Sterkel, Amanda L., Gottwald, Mildred D., Steinerman, Joshua R., Jochelson, Philip, Zomorodi, Katie, Hauser, Robert A.
Publicado 2021

Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia

por Thorpy, Michael J, Arnulf, Isabelle, Foldvary-Schaefer, Nancy, Morse, Anne Marie, Šonka, Karel, Chandler, Patricia, Hickey, Luke, Chen, Abby, Black, Jed, Sterkel, Amanda, Chen, Dan, Bogan, Richard K, Dauvilliers, Yves
Publicado 2022